Open company graph database — free web & API
Login

National Center of Neurology and Psychiatry

国立精神・神経医療研究センターNCNPAlias
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
2
§01

Basic information

BASIC
Head office
4-1-1 Ogawa Higashimachi, Kodaira City, Tokyo 187-8551
Chief executive
Capital
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

2
Muscle pathology diagnostic servicesMuscle repository management
§04

Related companies

2 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Japan Society of Psychiatry and Neurology
Group
Japan Shinyaku Co., Ltd.
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

3 EVENTS

This drug was designated as a target item under the pioneering review designation system in October 2015.Sources

From 2016 onwards: Phase I/II clinical trial by Nippon Shinyaku Co., Ltd.Sources

From 2020 onwards: Early conditional approval of NS-065/NCNP-01 based on results of physician-led and company-sponsored trials.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑